Article in Journal of nutritional science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 0 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 4 institutions in 1 country.
Mahmoud AmrDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, San Antonio, TX78249, USA.
Alia MallahDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, San Antonio, TX78249, USA.
Haneen AbusharkhGene and Linda Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, WA99164-6515, USA.
Bernard Van WieGene and Linda Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, WA99164-6515, USA.
Arda GozenSchool of Mechanical and Materials Engineering, Washington State University, Pullman, WA99164-2920, USA.
Juana MendenhallDepartment of Chemistry, Morehouse College, Atlanta, GA30314, USA.
Vincent IdoneRegeneron Pharmaceuticals Inc, Tarrytown, NY10591, USA.
Edwin TingstadInland Orthopedic Surgery and Sports Clinic, Pullman, WA99163, USA.
Nehal I Abu-LailDepartment of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, San Antonio, TX78249, USA.ORCID 0000-0002-2319-2450
Washington State University · USThe University of Texas at San Antonio · USMorehouse College · USRegeneron (United States) · US
Funding
TRAINING IN BIOTECHNOLOGY: EMPHASIS ON PROTEIN CHEMISTRYT32GM008336 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CALL, DOUGLAS R. · 1989 to 2023
$8.9M
NIGMS NIH HHS T32 GM008336
6 · The paper itself
Abstract
The
Indexed as
Dietary SupplementsOsteoarthritisAgedAged, 80 and overalpha-TocopherolAscorbic AcidCatechinCells, CulturedChondrocytesFemaleGallic AcidHumansInflammationMiddle AgedRNA, Messengeralpha-TocopherolAscorbic AcidCatechinGallic AcidRNA, MessengerAA or vitamin C, ascorbic acidAC, articular cartilageAgeArticualr cartilageBMI, body mass indexCatechin hydrateC, catechin hydrateECM, extracellular matrixGAG, glycosaminoglycanG, gallic acidhAChs, human articular chondrocytesMMP, metalloproteinaseNO, nitric oxideNOS, NO SynthaseNutraceuticalsOA, osteoarthritisOsteoarthritisTKR, total knee replacementTNF-α, tumour necrosis alphaWeightα or vitamin E, α-tocopherol
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.